Identity
HGNC
LOCATION
1p35.3
LOCUSID
ALIAS
CAHL,DF2,HGRG8,NY-REN-2
FUSION GENES
Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 51441
MIM: 610640
HGNC: 31675
Ensembl: ENSG00000198492
Variants:
dbSNP: 51441
ClinVar: 51441
TCGA: ENSG00000198492
COSMIC: YTHDF2
RNA/Proteins
Expression (GTEx)
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 37933909 | 2024 | WTAP enhances the instability of SYTL1 mRNA caused by YTHDF2 in bladder cancer. | 1 |
| 38013600 | 2024 | METTL3/YTHDF2 m6A axis mediates the progression of diabetic nephropathy through epigenetically suppressing PINK1 and mitophagy. | 2 |
| 38190128 | 2024 | FOXM1 Participates in Scleral Remodeling in Myopia by Upregulating APOA1 Expression Through METTL3/YTHDF2. | 0 |
| 38247171 | 2024 | YTHDF2 Is a Therapeutic Target for HCC by Suppressing Immune Evasion and Angiogenesis Through ETV5/PD-L1/VEGFA Axis. | 2 |
| 38380957 | 2024 | FTO promotes the progression of retinoblastoma through YTHDF2-dependent N6-methyladenosine modification in E2F3. | 0 |
| 38462165 | 2024 | YTHDF2 protein stabilization by the deubiquitinase OTUB1 promotes prostate cancer cell proliferation via PRSS8 mRNA degradation. | 0 |
| 38548669 | 2024 | Negative Regulation of LINC01013 by METTL3 and YTHDF2 Enhances the Osteogenic Differentiation of Senescent Pre-Osteoblast Cells Induced by Hydrogen Peroxide. | 0 |
| 38616512 | 2024 | YTHDF2 promotes gastric cancer progression and enhances chemoradiotherapy resistance. | 0 |
| 37933909 | 2024 | WTAP enhances the instability of SYTL1 mRNA caused by YTHDF2 in bladder cancer. | 1 |
| 38013600 | 2024 | METTL3/YTHDF2 m6A axis mediates the progression of diabetic nephropathy through epigenetically suppressing PINK1 and mitophagy. | 2 |
| 38190128 | 2024 | FOXM1 Participates in Scleral Remodeling in Myopia by Upregulating APOA1 Expression Through METTL3/YTHDF2. | 0 |
| 38247171 | 2024 | YTHDF2 Is a Therapeutic Target for HCC by Suppressing Immune Evasion and Angiogenesis Through ETV5/PD-L1/VEGFA Axis. | 2 |
| 38380957 | 2024 | FTO promotes the progression of retinoblastoma through YTHDF2-dependent N6-methyladenosine modification in E2F3. | 0 |
| 38462165 | 2024 | YTHDF2 protein stabilization by the deubiquitinase OTUB1 promotes prostate cancer cell proliferation via PRSS8 mRNA degradation. | 0 |
| 38548669 | 2024 | Negative Regulation of LINC01013 by METTL3 and YTHDF2 Enhances the Osteogenic Differentiation of Senescent Pre-Osteoblast Cells Induced by Hydrogen Peroxide. | 0 |
Citation
Dessen P
YTHDF2 (YTH N6-methyladenosine RNA binding protein 2)
Atlas Genet Cytogenet Oncol Haematol. 2003-06-01
Online version: http://atlasgeneticsoncology.org/gene/40815/ythdf2
